Terms: = Endocrine gland cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Staging
21 results:
1. Predictive Performance of Current Nodal staging Systems in Various Categories of Pancreatic cancer.
Lee W; Lee JB; Hong S; Park Y; Kwak BJ; Jun E; Song KB; Lee JH; Hwang DW; Kim SC
Ann Surg Oncol; 2022 Jan; 29(1):390-398. PubMed ID: 34423402
[TBL] [Abstract] [Full Text] [Related]
2. A case report of primary adrenal lymphoma: A rare but aggressive and invasive disease.
Yang Y; Xie W; Ren Y; Tian H; Chen T
Medicine (Baltimore); 2020 Jul; 99(28):e20938. PubMed ID: 32664092
[TBL] [Abstract] [Full Text] [Related]
3. Protein expressions of AIB1, p53 and bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis.
Liang M; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5134-5139. PubMed ID: 30178833
[TBL] [Abstract] [Full Text] [Related]
4. The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.
Weinlander E; Somnay Y; Harrison AD; Wang C; Cheng YQ; Jaskula-Sztul R; Yu XM; Chen H
J Surg Res; 2014 Jul; 190(1):191-7. PubMed ID: 24679699
[TBL] [Abstract] [Full Text] [Related]
5. Increased intratumoral interleukin 22 levels and frequencies of interleukin 22-producing CD4+ T cells correlate with pancreatic cancer progression.
Xu X; Tang Y; Guo S; Zhang Y; Tian Y; Ni B; Wang H
Pancreas; 2014 Apr; 43(3):470-7. PubMed ID: 24622082
[TBL] [Abstract] [Full Text] [Related]
6. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract] [Full Text] [Related]
7. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract] [Full Text] [Related]
8. [Histological and immunohistochemical profile of sporadic and familial medullary thyroid carcinoma].
Ríos A; Rodríguez JM; Febrero B; Acosta Ortega JM; Torregrosa N; Balsalobre M; Parrilla P
Endocrinol Nutr; 2011 Dec; 58(10):521-8. PubMed ID: 22047736
[TBL] [Abstract] [Full Text] [Related]
9. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Ho TY; Liou MJ; Lin KJ; Yen TC
Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
[TBL] [Abstract] [Full Text] [Related]
10. [Primary diffuse large B-cell lymphoma of testis: a clinicopathologic study of 14 cases].
Li D; Mi C; Zhao Y; Wang YL; Ma Y; Li YY; Xiang MH
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):461-5. PubMed ID: 17845759
[TBL] [Abstract] [Full Text] [Related]
11. Validation of the 6th edition AJCC Pancreatic cancer staging System: report from the National cancer Database.
Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
[TBL] [Abstract] [Full Text] [Related]
12. Adrenocortical tumors in Brazilian children: immunohistochemical markers and prognostic factors.
Sbragia L; Oliveira-Filho AG; Vassallo J; Pinto GA; Guerra-Junior G; Bustorff-Silva J
Arch Pathol Lab Med; 2005 Sep; 129(9):1127-31. PubMed ID: 16119984
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological significance of bcl-2 and Bax protein expression in human pancreatic cancer.
Dong M; Zhou JP; Zhang H; Guo KJ; Tian YL; Dong YT
World J Gastroenterol; 2005 May; 11(18):2744-7. PubMed ID: 15884114
[TBL] [Abstract] [Full Text] [Related]
14. Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.
Williams J; Lucas PC; Griffith KA; Choi M; Fogoros S; Hu YY; Liu JR
Gynecol Oncol; 2005 Feb; 96(2):287-95. PubMed ID: 15661210
[TBL] [Abstract] [Full Text] [Related]
15. Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II.
Skírnisdóttir I; Seidal T; Karlsson MG; Sorbe B
Int J Oncol; 2005 Jan; 26(1):177-83. PubMed ID: 15586238
[TBL] [Abstract] [Full Text] [Related]
16. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
Wang HX; Chen QK
Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
[TBL] [Abstract] [Full Text] [Related]
17. bcl-2 expression in a primary leiomyosarcoma of the ovary: a case report.
Bodner K; Bodner-Adler B; Czerwenka K; Hudelist G; Kimberger O; Leodolter S; Mayerhofer K
Wien Klin Wochenschr; 2003 Mar; 115(5-6):191-5. PubMed ID: 12741081
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer.
Fanning J; Brown S; Phibbs G; Kramer T; Zaher A
Int J Gynecol Cancer; 2002; 12(3):286-9. PubMed ID: 12060450
[TBL] [Abstract] [Full Text] [Related]
19. Follicular large cell lymphoma localized to the testis in children.
Pakzad K; MacLennan GT; Elder JS; Flom LS; Trujillo YP; Sutherland SE; Meyerson HJ
J Urol; 2002 Jul; 168(1):225-8. PubMed ID: 12050548
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
[TBL] [Abstract] [Full Text] [Related]
[Next]
